BioNexus Gene Lab CorpBioNexus Gene Lab CorpBioNexus Gene Lab Corp

BioNexus Gene Lab Corp

No trades
See on Supercharts

BGLC fundamentals

An in-depth look to BioNexus Gene Lab Corp operating, investing, and financing activities

BGLC free cash flow for Q2 24 is -662.33 k USD. For 2023, BGLC free cash flow was -1.4 M USD and operating cash flow was -1.25 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth